BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4404626)

  • 21. Clinical evaluation of a new depot neuroleptic. A pilot study with pipotiazine undecylenate (19.551 R.P.).
    Ahlfors UG; Katila O
    Acta Psychiatr Scand Suppl; 1973; 241():43-9. PubMed ID: 4147510
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 23. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 25. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 26. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
    Bruck J; Guss H
    Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320
    [No Abstract]   [Full Text] [Related]  

  • 27. General evaluation of pipotiazine palmitate in hospitalized and open ward patients with functional psychosis.
    Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 241():57-67. PubMed ID: 4147512
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacokinetics of pipothiazine palmitate, after intramuscular administration in schizophrenic patients].
    Blanc M; Girard M; Granier F; Escande M; Cotonat J
    Therapie; 1986; 41(1):27-30. PubMed ID: 2871636
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
    Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with 19.552 R.P. in Nordic countries.
    Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 246():42-7. PubMed ID: 4148911
    [No Abstract]   [Full Text] [Related]  

  • 31. [Parenteral form of pipothiazine in the treatment of endogenous psychoses].
    Matkowski K; Martenka E; Nobis T
    Psychiatr Pol; 1984; 18(6):567-70. PubMed ID: 6152666
    [No Abstract]   [Full Text] [Related]  

  • 32. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
    Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
    Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
    [No Abstract]   [Full Text] [Related]  

  • 34. An open study with a new long-acting neuroleptic.
    Fleischhauer J; Angst J; Padrutt A; Vetter P
    Act Nerv Super (Praha); 1973 May; 15(2):85-6. PubMed ID: 4752678
    [No Abstract]   [Full Text] [Related]  

  • 35. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.
    Astrup C; Grimgård A; Hebnes K; Kruse-Jensen A; Lid M
    Acta Psychiatr Scand; 1974; 50(5):481-91. PubMed ID: 4156624
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pipothiazine undecylenic ester. Piperidinated phenothiazine with prolonged action time].
    Delay J; Lemperiere T; Deniker P; Peron-Magnan PN; Feline A; Ginestet D; Colonna L
    Presse Med (1893); 1971 Jun; 79(28):1293-4. PubMed ID: 5563081
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of schizophrenia.
    Bennett DH
    Br J Psychiatry; 1975; Spec No 9():48-54. PubMed ID: 241452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.